 |
 |
| |
Since becoming The
Automation Partnership’s CEO in 2009,
David Newble has been reshaping the company’s
business strategy, to build on its core
competence in automated cell culture and
broaden the product portfolio. |
| |
To reflect
this change, the senior management team
has decided now is the right time to
rename the company |
| |
 |
| |
In this video briefing David
shares his personal views on The Automation
Partnership’s evolution and what it
means as TAP Biosystems moves forward into
new markets and new territories. |
| |
Download
a transcript of David Newble's Video Briefing
(260k PDF) |
| |
|
